S. Sherlock

6.1k total citations · 4 hit papers
94 papers, 4.6k citations indexed

About

S. Sherlock is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, S. Sherlock has authored 94 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hepatology, 46 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in S. Sherlock's work include Liver Disease Diagnosis and Treatment (40 papers), Liver Disease and Transplantation (26 papers) and Liver Diseases and Immunity (20 papers). S. Sherlock is often cited by papers focused on Liver Disease Diagnosis and Treatment (40 papers), Liver Disease and Transplantation (26 papers) and Liver Diseases and Immunity (20 papers). S. Sherlock collaborates with scholars based in United Kingdom, Australia and United States. S. Sherlock's co-authors include Howard C. Thomas, Roy Fox, F. J. Dudley, Rachel S. Mulligan, Gordon Cook, Owen Epstein, I M Roitt, Deborah Doniach, Josephine G. Walker and A. E. Read and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

S. Sherlock

90 papers receiving 3.8k citations

Hit Papers

Controlled Prospective Tr... 1951 2026 1976 2001 1971 1972 1966 1951 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
S. Sherlock 2.5k 2.5k 965 518 371 94 4.6k
Hemming Poulsen 4.1k 1.6× 4.2k 1.7× 1.2k 1.2× 343 0.7× 343 0.9× 65 6.7k
G Korb 3.9k 1.5× 3.9k 1.6× 754 0.8× 328 0.6× 152 0.4× 80 5.8k
D. R. Triger 2.4k 0.9× 2.2k 0.9× 1.0k 1.1× 166 0.3× 199 0.5× 98 4.0k
Santiago J. Muñoz 2.8k 1.1× 2.0k 0.8× 1.3k 1.3× 565 1.1× 209 0.6× 106 4.1k
P. Michielsen 1.5k 0.6× 2.1k 0.9× 662 0.7× 211 0.4× 286 0.8× 219 4.0k
Hanne Prytz 2.7k 1.1× 2.1k 0.8× 1.7k 1.7× 227 0.4× 1.0k 2.7× 73 4.0k
Élie Serge Zafrani 1.2k 0.5× 1.2k 0.5× 1.1k 1.1× 283 0.5× 416 1.1× 85 3.9k
Arie Regev 2.6k 1.0× 2.8k 1.1× 936 1.0× 380 0.7× 213 0.6× 95 4.7k
Gerald Klatskin 1.9k 0.8× 2.1k 0.8× 1.8k 1.9× 456 0.9× 1.0k 2.8× 92 5.5k
Archie H. Baggenstoss 2.3k 0.9× 3.2k 1.3× 1.7k 1.8× 279 0.5× 975 2.6× 125 6.0k

Countries citing papers authored by S. Sherlock

Since Specialization
Citations

This map shows the geographic impact of S. Sherlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Sherlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Sherlock more than expected).

Fields of papers citing papers by S. Sherlock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Sherlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Sherlock. The network helps show where S. Sherlock may publish in the future.

Co-authorship network of co-authors of S. Sherlock

This figure shows the co-authorship network connecting the top 25 collaborators of S. Sherlock. A scholar is included among the top collaborators of S. Sherlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Sherlock. S. Sherlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherlock, S.. (2021). Hyperbaric Protocols for Idiopathic Sudden Sensorineural Hearing Loss. The Journal of International Advanced Otology. 17(6). 584–585.
2.
Morgan, Marsha Y., Ron Reshef, Rahul Shah, et al.. (1984). Impaired oxidation of debrisoquine in patients with perhexiline liver injury.. Gut. 25(10). 1057–1064. 131 indexed citations
3.
Weller, I V, Peter Karayiannis, Anna S. Lok, et al.. (1983). Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.. Gut. 24(11). 1061–1063. 34 indexed citations
4.
Weller, Ian, et al.. (1982). Effects of prednisolone/azathioprine in chronic hepatitis B viral infection.. Gut. 23(8). 650–655. 54 indexed citations
5.
Epstein, Owen, Robert Dick, & S. Sherlock. (1981). Prospective study of periostitis and finger clubbing in primary biliary cirrhosis and other forms of chronic liver disease.. Gut. 22(3). 203–206. 26 indexed citations
6.
Smith‐Laing, G., et al.. (1981). Results of portal decompression in patients with primary biliary cirrhosis.. Gut. 22(5). 345–349. 9 indexed citations
7.
Burt, Alastair D., et al.. (1980). HBSAG-POSITIVE CHRONIC LIVER-DISEASE - INHIBITION OF VIRAL REPLICATION BY HIGHLY SOLUBLE ADENINE-ARABINOSIDE 5'-MONO-PHOSPHATE (ARA-AMP). UCL Discovery (University College London). 1 indexed citations
9.
Summerfield, J.A., John W. Scott, M. Berman, et al.. (1980). Benign recurrent intrahepatic cholestasis: studies of bilirubin kinetics, bile acids, and cholangiography.. Gut. 21(2). 154–160. 24 indexed citations
10.
Thomas, Howard C., et al.. (1978). Immune complexes in acute and chronic liver disease.. PubMed Central. 31(2). 150–7. 129 indexed citations
11.
Chiaramonte, M., Jenny Heathcote, Megan Crees, & S. Sherlock. (1977). Detection, by three techniques, of hepatitis B surface antigen (HBsAg) and determination of HBsAg and anti-HBs titres in patients with chronic liver disease.. Gut. 18(1). 1–6. 7 indexed citations
12.
Jain, S, H. C. Thomas, & S. Sherlock. (1977). Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(1). 10–5. 18 indexed citations
13.
Sánchez‐Tapias, José‐María, Howard C. Thomas, & S. Sherlock. (1977). Lymphocyte populations in liver biopsy specimens from patients with chronic liver disease.. Gut. 18(6). 472–475. 53 indexed citations
14.
MOULT, P. J. A. & S. Sherlock. (1975). Halothane-Related Hepatitis<subtitle>A CLINICAL STUDY OF TWENTY-SIX CASES</subtitle>. QJM. 44(173). 99–114. 48 indexed citations
15.
James, Oliver, et al.. (1974). 67 Gallium scanning in the diagnosis of liver disease. Gut. 15(5). 404–410. 27 indexed citations
16.
Sherlock, S., et al.. (1974). The epidemiology of primary biliary cirrhosis: A survey of mortality in England and Wales. Gut. 15(6). 473–479. 38 indexed citations
17.
Barry, Michael A., et al.. (1969). Differential ferrioxamide test in haemochromatosis and liver disease. Gut. 10(9). 697–704. 17 indexed citations
18.
Read, A. E., S. Sherlock, & C. V. Harrison. (1963). Active `juvenile' cirrhosis considered as part of a systemic disease and the effect of corticosteroid therapy. Gut. 4(4). 378–393. 173 indexed citations
19.
Sherlock, S.. (1962). Alcohol and disease.. British Medical Bulletin. 38(1). 1–114. 16 indexed citations
20.
Sherlock, S., et al.. (1952). Testosterone Therapy for the Pruritus of Obstructive Jaundice. BMJ. 2(4797). 1289–1291. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026